BusinessAvid Bioservices to Present at the 30th Annual ROTH ConferenceBy Nasdaq OMXMar 6, 2018, 1:05 PM UTC
BusinessAvid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease CandidateBy Nasdaq OMXMar 1, 2018, 1:05 PM UTC
BusinessPublicis Health’s Contact Center Achieves J.D. Power CertificationBy Nasdaq OMXFeb 28, 2018, 1:01 PM UTC
BusinessAXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid MoleculesBy Nasdaq OMXFeb 27, 2018, 2:02 PM UTC
BusinessPreveCeutical Announces Appointment of Dr. Maher Khaled as Director of International OperationsBy Nasdaq OMXFeb 26, 2018, 2:30 PM UTC
BusinessAvid Bioservices Announces Resignation of Chief Financial OfficerBy Nasdaq OMXFeb 26, 2018, 1:05 PM UTC
BusinessCBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid AddictionBy Nasdaq OMXFeb 21, 2018, 2:01 PM UTC
BusinessCURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to UplistingBy Nasdaq OMXFeb 21, 2018, 11:00 AM UTC
